PUD in children By Jazgul Abjamilova

Peptic Ulcer Disease (PUD) in Children By Abhinav Kumar Sharma Kartikay Dhillon Himanshu Jat Vedant Lahakodiya Under the Guidance of Jazgul Abjamilova, Proff. Deptt of Pediatrics Osh State University, International Medical Faculty Abstract Peptic Ulcer Disease (PUD) in children, though less common than in adults, is a significant gastrointestinal condition characterized by the formation of ulcers in the stomach or duodenum. The primary cause in pediatric populations is Helicobacter pylori (H. pylori) infection, accounting for 50-70% of cases, followed by the use of non-steroidal anti-inflammatory drugs (NSAIDs) and stress-related mucosal damage. The pathophysiology involves an imbalance between aggressive factors (acid, pepsin, H. pylori) and defensive factors (mucosal barrier, blood flow, prostaglandins), leading to mucosal erosion and ulceration. Clinical presentation in children can be atypical, with symptoms ranging from epigastric pain and nausea to non-specific complaints like irritability or failure to thrive. Diagnosis relies on a combination of clinical history, non-invasive H. pylori testing (e.g., stool antigen or urea breath tests), and upper gastrointestinal endoscopy, which remains the gold standard for definitive diagnosis and biopsy. Treatment focuses on eradicating H. pylori (using triple or quadruple therapy), reducing acid secretion (with proton pump inhibitors or H2-receptor antagonists), and promoting mucosal healing. Complications such as hemorrhage, perforation, or gastric outlet obstruction require urgent intervention. Prevention strategies include improving sanitation to reduce H. pylori transmission, judicious use of NSAIDs, and early detection of symptoms. Despite its challenges, PUD in children has a favorable prognosis with timely and appropriate treatment. Ongoing research into vaccine development, antibiotic resistance, and non-invasive biomarkers holds promise for improving diagnosis, treatment, and prevention in the future. This comprehensive review highlights the importance of a multidisciplinary approach to managing PUD in pediatric populations, ensuring optimal outcomes and quality of life for affected children. Introduction Ulcer Disease (PUD) is a condition characterized by the formation of open sores (ulcers) in the lining of the stomach, duodenum, or other parts of the gastrointestinal tract. While PUD is more commonly associated with adults, it can also occur in children, albeit less frequently. This detailed explanation covers the etiology, pathophysiology, clinical presentation, diagnosis, treatment, and prognosis of PUD in children. 1. Etiology and Risk Factors The development of PUD in children is influenced by a combination of factors, including: a) Helicobacter pylori (H. pylori) Infection - Primary Cause : H. pylori is the most common cause of PUD in children, accounting for 50-70% of cases. - Transmission : Fecal-oral or oral-oral routes, often through contaminated food, water, or close contact with infected individuals. - Pathophysiology : H. pylori colonizes the gastric mucosa, producing urease that neutralizes stomach acid and damages the mucosal lining, leading to ulcer formation. b) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) - Mechanism : NSAIDs inhibit cyclooxygenase (COX) enzymes, reducing prostaglandin production, which is essential for mucosal protection. - Common NSAIDs : Ibuprofen, aspirin, and naproxen are frequently implicated. c) Stress-Related Mucosal Damage - Acute Illness : Severe stress from critical illnesses (e.g., sepsis, burns, or trauma) can lead to stress ulcers. - Mechanism : Reduced blood flow to the gastric mucosa and increased acid secretion contribute to ulcer formation. d) Other Causes - Zollinger-Ellison Syndrome : A rare condition caused by gastrin-secreting tumors, leading to excessive acid production. - Crohn’s Disease : Inflammatory bowel disease can cause ulcers in the stomach or duodenum. - Idiopathic : Some cases have no identifiable cause. Pathophysiology The emergence of Peptic Ulcer Disease (PUD) in children results from the complex interaction of multiple factors which disturb the equilibrium between aggressive factors (acid, pepsin, and H. pylori) and defensive factors (mucosal barrier, blood supply, prostaglandins). To elaborate further, let us breakdown what was previously stated: 1. H. pylori - Colonization : H. pylori colonizes the gastric epithelium, especially in the antrum region, and synthesizes urease which neutralizes the acid in the stomach for its survival. - Toxin Production : Variance factors such as ___CagA___ (cytotoxin associated gene A) and ___VacA___ (vacuolating cytotozin A) tear down epithelial curtain perfusion along with inflammation. - Immune Response : The chronic gastritis is a result of immune response from the host, which, in absence of treatment, progresses to ulceration. 2. NSAID - Prostaglandin Inhibition : NSAIDs also block the COX (cyclooxygenase) enzymes NSAIDs therefore blocking prostalgandins, responsible for the production of mucus blood flow and its sustaining. - Direct Toxicity : The Mucosal lining of the stomach may become affected directly by NSAIDs through inflammation. 3. Specific Ulcers Relieved By Stress - Ishemia : The gastric mucosa’s ability to perfuse with blood is hampered by critical illnesses (sepsis, burns trauma) which then causes it the succum to the acid damage. 4. Genetic and Environmental Factors - Genetic Predisposition : Some genetic mutations (e.g., IL-1β, TNF-α) are responsible for H. pylori infection and consequent peptic ulcer. - Environmental Triggers : Absence of proper sanitation, the overloading shelters, and the disadvantageous position of the inhabitants, are the reasons why H. pylori is more common. Diagnostic Challenges in Children The diagnosis of PUD in children can be quite problematic due to the non-specific symptoms and inability of smaller children to communicate disturbingness of their condition . Here’s a deeper look: 1. Atypical Presentations - The young might instead make feeding difficulty, irritability, or failure to thrive their symptom presentation other than the classical-style pain the stomach may♯ . Older children might tell of vague abdominal discomfort that is hard to pinpoint in the abdomen. 2. Limitations of Diagnostic Tests - Non-Invasive Tests : However, stool antigen tests and urea breath tests, which are used to detect H. pylori, can also give wrong results in small children due to a low number of bacteria. - Endoscopy : On the other hand, endoscopy is an invasive b”t can be a resource and a limitation for troubled areas. 3. Differential Diagnosis - PUD symptoms can mimic other conditions, such as: - Gastroesophageal Reflux Disease (GERD) - Functional Abdominal Pain - Inflammatory Bowel Disease (IBD) - Lactose Intolerance Treatment Strategies Treatment of PUD in children requires a multifaceted approach targeted precisely to the reason that caused the disease itself. Here is a more elaborate explanation: 1. H. pylori Eradication - First-Line Therapy : - Triple Therapy : PPI (e.g., omeprazole) + a for 10-14 days. - Quadruple Therapy : PPI + bismuth subsalicylate + metronidazole + tetracycline on the other side (for older children or in regions with high clarithromycin resistance). - Adherence : On the other hand, if a physician forgets to take a few pills out of a packet or gives an upset stomach, he/she needs to reassure the patient or change timing but never try a different drug. - Follow-Up Testing : After the patient is treated with antibiotics, the stool sample will be retested in 4 to 6 weeks. Upon discharge, this test will also be done. - Confirm and Follow-Up Testing : The only way to verify that you have been cured is to take a stool antigen test or a urea breath test 4-6 weeks after the treatment. 2. Acid Suppression - Proton Pump Inhibitors (PPIs) : - Mechanism : Block the H+/K+ pump of the gastric parietal cells, thus, the acid secretion is reduced. - Examples : Omeprazole, esomeprazole, lansoprazole. Duration : Typically prescribed for 4-8 weeks, depending on ulcer severity. - H2-Receptor Antagonists : - Mechanism : Block histamine receptors on parietal cells, reducing acid secretion. - Examples : Ranitidine, famotidine. - Use : Less potent than PPIs but may be used as an alternative. 3. Mucosal Protectants - Sucralfate : - Forms a protective barrier over the ulcer, promoting healing. - Often used in combination with acid-suppressing medications. - Antacids : - Provide symptomatic relief by neutralizing stomach acid. - Less commonly used as primary therapy due to limited healing effects. 4. Lifestyle and Dietary Modifications - Avoid Triggers : Spicy foods, caffeine, and acidic beverages can exacerbate symptoms. - Small, Frequent Meals : Helps reduce acid production and prevent gastric distension. - Stress Management : Counseling or relaxation techniques may be beneficial, especially in stress-related ulcers. 5. Management of Complications - Hemorrhage : - Endoscopic hemostasis (e.g., clipping, cauterization). - Blood transfusion if significant blood loss occurs. - Perforation : - Emergency surgery to repair the perforation. - Gastric Outlet Obstruction : - Endoscopic dilation or surgical intervention. Emerging Research and Future Directions Research on PUD in children is ongoing, with a focus on improving diagnosis, treatment, and prevention. Key areas of interest include: 1. Vaccine Development - Efforts are underway to develop a va